Skip to main content

Table 3 MAP4K4-specific small-molecule inhibitors

From: MAP4K4: an emerging therapeutic target in cancer

Name

Type

Specificity

Biological/Preclinical disease model

Clinical trial

Ref.

GNE-495

KI

MAP4K4

Angiogenesis in mouse model

NA

[12, 53]

GNE-220

KI

MAP4K4

Angiogenesis in mouse model

NA

[12]

PF-6260933

KI

MAP4K4

Vascular inflammation, atherosclerosis

NA

[18, 54]

4-Hydroxy-2-pyridone

KI

MAP4K4

Neuroblastoma cell

NA

[55]

  1. KI kinase inhibitor, NA not available